Lactulose

# Lactulose ## Overview - **Classification**: Osmotic laxative; ammonia reducer (synthetic disaccharide) - **Mechanism**: Metabolized by colonic bacteria to acids, lowering pH and drawing water into the colon (osmotic effect). In hepatic encephalopathy, it traps ammonia (NH3) as ammonium (NH4+) for excretion. ## Primary Indications 1. **Chronic Constipation** - To promote regular bowel movements. 2. **Hepatic Encephalopathy (HE)** - Treatment and prevention of systemic ammonia toxicity. ## Adult Dosing ### Standard Dosing **Chronic Constipation** - **Dose**: **10-20 g** (**15-30 mL**) - **Frequency**: Once daily, may increase to twice daily. - **Route**: Oral - **Goal**: Produce 1-2 soft stools daily. Onset 24-48 hours. **Hepatic Encephalopathy** - **Acute Treatment**: - **Dose**: **30-45 mL** (**20-30 g**) - **Frequency**: Every 1-2 hours until 2-3 soft stools are produced. - **Route**: Oral - **Maintenance Treatment**: - **Dose**: **30-45 mL** (**20-30 g**) - **Frequency**: 3-4 times daily - **Route**: Oral - **Goal**: Maintain 2-3 soft stools daily and improve mental status. - **Rectal Enema (if oral not feasible)**: - **Dose**: **300 mL** (**200 g**) mixed with **700 mL** water - **Frequency**: Retain for 30-60 min; repeat every 4-6 hours as needed. - **Route**: Rectal ### Dose Adjustments - **Renal Impairment**: No specific adjustment needed as lactulose is minimally absorbed. - **Hepatic Impairment**: No specific adjustment needed. - **Elderly Patients**: Start with lower doses and titrate carefully to avoid dehydration/electrolyte imbalance. ## Pediatric Dosing ### Neonates (0-28 days) - **Constipation**: - **Dose**: **2.5-5 mL** (**1.67-3.33 g**) - **Frequency**: Once daily or divided twice daily. - **Maximum**: **10 mL/day** (**6.67 g/day**). - **Special Notes**: Use with caution. Ensure adequate hydration. ### Infants (1-12 months) - **Constipation**: - **Dose**: Initial **2.5-10 mL** (**1.67-6.67 g**) - **Frequency**: Once daily or divided BID/TID. - **Maximum**: **40 mL/day** (**26.7 g/day**). - **Special Notes**: Titrate to achieve 1-2 soft stools daily. - **Hepatic Encephalopathy**: - **Dose**: **2.5-10 mL** (**1.67-6.67 g**) - **Frequency**: Daily, divided 3-4 times/day. - **Goal**: 2-3 soft stools daily. ### Children (1-12 years) - **Constipation**: - **Dose**: Initial **5-10 mL** (**3.33-6.67 g**) - **Frequency**: Once daily. - **Maximum**: **40 mL/day** (**26.7 g/day**). - **Special Notes**: Titrate to achieve 1-2 soft stools daily. - **Hepatic Encephalopathy**: - **Dose**: Initial **15-30 mL** (**10-20 g**) - **Frequency**: Daily, divided 3-4 times/day. - **Maximum**: **180 mL/day** (**120 g/day**). - **Goal**: 2-3 soft stools daily. ### Adolescents (13-18 years) - **Dose**: Similar to adult starting doses for respective indications. - **Maximum**: Follow adult maximum doses (**60 mL/day for constipation, 180 mL/day for HE**). ## Safety Information ### Contraindications - **Absolute**: Galactosemia (contains galactose), acute abdomen, intestinal obstruction, hypersensitivity. - **Relative**: Diabetic patients (use with caution, monitor blood glucose, may contain small amounts of sugars). ### Common Adverse Effects - **Very Common (>10%)**: Flatulence, abdominal discomfort/cramping, abdominal distention. - **Common (1-10%)**: Diarrhea, nausea, vomiting. - **Serious but Rare**: Dehydration, electrolyte imbalance (hypokalemia, hypernatremia) from excessive diarrhea. ### Key Drug Interactions - **Other Laxatives**: Increased risk of severe diarrhea and electrolyte imbalance. Avoid concurrent use. - **Antacids (non-absorbable)**: May reduce the desired drop in colonic pH, potentially decreasing lactulose efficacy. Monitor for reduced effect. - **Oral Antibiotics (broad-spectrum)**: May reduce the efficacy of lactulose by altering colonic flora needed for metabolism. Monitor for reduced effect. - **Diuretics (e.g., Thiazides, Loop)**: Increased risk of hypokalemia with chronic use, especially in HE patients. Monitor electrolytes. ## Monitoring & Follow-up - **Before Treatment**: Baseline electrolytes (if patient at risk for imbalance or treating HE), fluid status. - **During Treatment**: - **Constipation**: Number and consistency of stools. - **Hepatic Encephalopathy**: Mental status, serum ammonia levels (though clinical response is primary), number/consistency of stools, electrolyte levels (especially K+ and Na+), fluid status. - **Clinical Signs**: Watch for excessive diarrhea, abdominal pain, dehydration (dry mouth, decreased urine output), worsening mental status (HE). ## Clinical Pearls - 💡 **Taste**: Lactulose has a sweet, sometimes unpalatable taste. Mix with water, juice, or milk for easier administration. - 💡 **Onset**: For constipation, effects may take **24-48 hours**. For HE, more rapid action is expected with initial high doses. - 💡 **HE Goal**: Aim for **2-3 soft bowel movements daily** to ensure adequate ammonia clearance. Over-treatment can lead to dehydration and electrolyte imbalance. - 💡 **Initial Side Effects**: Flatulence and abdominal cramping are common at the start of therapy and usually subside. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.